Related Experiment Video
Updated: Jan 21, 2026

Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis
Published on: January 7, 2017
ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes
G Michelle Ducasa1, Alla Mitrofanova1,2, Shamroop K Mallela1
1Katz Family Division of Nephrology and Hypertension/ Drug Discovery Center, Department of Medicine, University of Miami, Miami, Florida, USA.
ATP-binding cassette A1 (ABCA1) deficiency causes cardiolipin accumulation and mitochondrial dysfunction, leading to diabetic kidney disease (DKD). Therapies targeting ABCA1 or cardiolipin peroxidation may treat DKD.
Area of Science:
- Mitochondrial Biology
- Nephrology
- Lipid Metabolism
Background:
- ATP-binding cassette A1 (ABCA1) loss-of-function mutations cause cardiolipin accumulation in Tangier disease fibroblasts.
- ABCA1 expression is suppressed in diabetic kidney disease (DKD) glomeruli and podocytes exposed to DKD sera.
- ABCA1 deficiency in podocytes impairs mitochondrial function and oxidative phosphorylation (OXPHOS).
Purpose of the Study:
- To investigate the role of ABCA1 in diabetic kidney disease (DKD) pathogenesis.
- To determine if cardiolipin accumulation mediates ABCA1-dependent podocyte injury in DKD.
- To explore therapeutic strategies for DKD targeting ABCA1 or cardiolipin metabolism.
Main Methods:
- Utilized siRNA to knockdown ABCA1 in podocytes, assessing mitochondrial function and cardiolipin levels.
- Generated podocyte-specific Abca1 knockout mice to evaluate DKD susceptibility.
- Administered ABCA1 inducers and elamipretide (a cardiolipin peroxidation inhibitor) to treat DKD models.
- Investigated the role of free cholesterol by genetically deleting sterol-o-acyltransferase-1 (SOAT1).
Main Results:
- ABCA1 knockdown in podocytes reduced oxygen consumption and increased cardiolipin accumulation.
- Podocyte-specific Abca1 deletion exacerbated DKD susceptibility in mice.
- Pharmacological ABCA1 induction improved established DKD.
- Free cholesterol accumulation (via SOAT1 deletion) did not cause glomerular injury, indicating cardiolipin's central role.
- Elamipretide inhibited cardiolipin peroxidation, improving DKD in vivo and preventing podocyte injury in vitro and in vivo.
Conclusions:
- A pathway linking ABCA1 deficiency to cardiolipin-driven mitochondrial dysfunction in DKD is identified.
- Cardiolipin accumulation, not free cholesterol, mediates ABCA1-dependent podocyte injury in DKD.
- ABCA1 inducers and cardiolipin peroxidation inhibitors represent potential therapeutic strategies for DKD.
Related Concept Videos
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
ATP Yield
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
Animal Mitochondrial Genetics
Hydrolysis of ATP
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...

